Roundtable: 1 Stock to Buy in August

As we do each month, we asked a handful of our top analysts across sectors for one stock that looks especially compelling right now. Here are the companies they singled out.

Dan Caplinger: My stock for the month is Greenbrier (NYSE: GBX  ) , a small company that focuses on selling and leasing various types of railcars for the railroad industry. Railroads have done exceedingly well in the past several years, as high fuel costs made it much more efficient to transport commodities over long distances by rail. The rise in commodity demand that we saw in the mid-2000s also bolstered the industry, and when railroads needed more railcars to meet their customers' demand, they turned to Greenbrier.

More recently, a slowdown in demand for many commodities, especially coal, has hurt railroad shipping volume. But in order to replace lost coal volume, several railroads have turned to transporting crude oil by rail, helping to serve hard-to-reach areas for which pipeline capacity is insufficient. That in turn has forced railroad companies to obtain tank cars for oil transport, and Greenbrier has been able to meet those needs as well. Given the high price of oil, the rising production from unconventional energy plays in locations that railroads are best enabled to serve, and the relative lack of strong competition, Greenbrier should have plenty of room to grow in helping the railroad industry address its own customers' shipping requirements.

Justin Loiseau: Utility NextEra Energy (NYSE: NEE  ) beat earnings expectations again this month -- and it's not a fluke. Although NextEra is the nation's largest producer of renewable energies, its operations run like a well-oiled machine. The company's Florida-regulated utility keeps pulling in cash, while its generation division continues to expand and diversify. The company has capitalized on production tax credits to boost its wind capacity past 10,000 net MW, but it's also modernizing nuclear projects and adding on to natural gas. In July, NextEra announced a $3 billion joint venture with Spectra Energy to bring Florida its third major natural gas pipeline. The company's stock is priced at a premium to competitors (up 21% over the last 12 months), and its relatively low 3.1% dividend yield has many income investors unenthused. But with formidable fundamentals and 5% to 7% annual EPS growth estimated for the foreseeable future, NextEra's still got room to rise.

Maxx Chatsko: Monsanto (NYSE: MON  ) is surely a controversial company, but the recent slide below $100 per share could be a buying opportunity for long-term investors. Full-year earnings are expected to grow more than 20% in 2013 and by double digits in 2014, demonstrating that the company still has future growth opportunities ahead of it. In fact, the company expects to sell a record volume of corn seeds in its 2013 fiscal year, which would be the third consecutive record year.

While seed sales are down a bit year over year so far, recent expansion into quickly growing -- and incredibly fertile -- South American countries has been accelerating. A recent decision should also boost sales of Roundup in the United States, which grew 24% for the first nine months of the current fiscal year. Monsanto may receive an unfair amount of criticism for its business (ever hear anyone lament Syngenta, DuPont, or Bayer GMO products?), but the fundamentals from an investing point of view remain enticing. 

Matt DiLallo: This month I am going back to the well, so to speak, and picking Nuverra Environmental Solutions (NYSE: NES  ) . Back in March I had gone with what was then known as Heckmann. A name change and a roller-coaster ride later, and I think the stock is even more compelling than before.

For those not familiar with the company, Nuverra provides environmental services to oil and gas companies, particularly surrounding the water used in fracking. Its core business is to treat and recycle water produced during the fracking process. Thought of another way, Nuverra is the company that's working to clean up the image of fracking.

The problem lately is that the company just can't seem to catch a break. Its Bakken business has been hit by bad weather, which slowed growth. Meanwhile, its operations in the Marcellus and Utica grew faster than it could handle, forcing Nuverra to subcontract a lot of work, which hit margins. To top things off, the company is having issues in the Eagle Ford causing it to revamp the management team.

All that said, Nuverra is in the right place at the right time to really enhance the growth of U.S. energy production. Its focus on water is of critical importance to the industry and its recent deal with Halliburton focusing on on-site water recycling could be an industry game-changer. These factors taken together, Nuverra is a very compelling opportunity, made even more intriguing as its recent missteps have put the company's stock in the bargain bin. 

Keith Speights: If you can handle high volatility, Questcor Pharmaceuticals  (NASDAQ: QCOR  ) looks to be a good pick for August. While there have been plenty of heart-stopping ups and downs along the way, Questcor ranks as one of the three best-performing biotech stocks over the past decade. The company's success stems from positioning Acthar, a drug first developed in the 1950s, as a treatment for diseases including infantile spasms, nephrotic syndrome, and multiple sclerosis.

Questcor reported year-over-year revenue growth of 64% in the second quarter. Earnings for the quarter nearly doubled compared to the same period in 2012. Questcor's shares jumped more than 18% the day after those results were announced, and are now up around 100% year to date.

Even with these huge gains, the stock appears to have plenty of room to run. Analysts surveyed by Thomson Reuters expect earnings growth to average 26% annually over the next few years. I think that growth should be achievable as Questcor continues to expand by marketing Acthar for new indications.

Questcor's trailing and forward price-to-earnings multiples currently stand at 18.9 and 12.6, respectively. The stock looks inexpensive considering the strong growth prospects. And, unlike most biotechs, Questcor sports a nice dividend yield of 2%.

What's the downside? That aforementioned volatility. There are plenty of short-sellers who think that Acthar's growth is unsustainable. My view is that they're wrong, but buying Questcor shares could treat investors to a bumpy ride. 

Jay Jenkins: This month I recommend taking a good long look at Citigroup (NYSE: C  ) . Citi took a beating during the financial crisis, falling from a high of more than $200 in 2008 to just above $10 in 2009. More recently, the stock has rebounded strongly, doubling over the past 12 months to around $50 as of this writing. I think this run is just the beginning. Among the four U.S. mega banks, Citigroup is by far the most international, which over the next 20 years should be a major advantage as capital flows increasingly move overseas. Citi has been vocal in its embrace of modern consumer technology, winning recognition for its mobile app, its leadership in mobile payments, and its revamped online platform. And of all the improvements at Citi over the past five years, the improvement in its capital position may be the most impressive. All in all, Citi has rebounded from past mistakes, has one of the best balance sheets on Wall Street, and is positioned for long-term competitive advantage in the future. 

Sean Williams: Feel free to call me biased because it's currently the largest holding in my personal portfolio, but August is a month that's been a long time coming for shareholders of Thompson Creek Metals (NYSE: TC  ) .

The big news that awaits in August, aside from Thompson Creek's second-quarter results, is the expected opening of the Mt. Milligan mine with its approximately 2.1 billion pounds of copper and 6 million ounces of gold reserves. The mine itself has cost about twice as much as initially planned ($1.5 billion versus initial estimates around $750 million), which necessitated Thompson Creek to sell off a 52.25% royalty stake in its gold production to Royal Gold in exchange for cash to help complete the project. The goal with Mt. Milligan is to move beyond producing just molybdenum and diversify into more stable and usable commodities like copper and gold.

Thompson Creek has taken quite the beating as spot gold prices have dropped well off their highs and molybdenum prices have dropped around 29% over the trailing year. But this is no longer a molybdenum story or even a gold story: Thompson Creek is a copper play! If you'll notice, copper has held up remarkably well compared to other metals in recent months because China and other emerging markets can't seem to get enough of the versatile metal. With Thompson Creek remaining on schedule throughout its mine build-out, I have a strong suspicion it could really surprise Wall Street over the coming years once this mine is commissioned. 

Jim Gillies:  Bridgepoint Education  (NYSE: BPI  ) saw significantly reduced uncertainty in mid-July with word that its academic institution Ashford University had been granted accreditation by The Western Association of Schools and Colleges (WASC) after being denied last year. Another denial would have left Bridgepoint scrambling to relocate the bulk of its operations to the central U.S. domicile of its current accrediting body (the Higher Learning Commission, or HLC) -- and it would have had to address the academic issues that had previously led HLC to put Ashford on notice regarding accreditation. All this is important because an educator lacking accreditation cannot access Title IV funding -- the ultimate source of nearly 87% of Bridgepoint's revenue.

Thankfully, Bridgepoint's hard work and money spent over the past year addressing WASC's concerns has paid off. And now, even though the stock is up about 30% post-accreditation receipt, it's a better bargain due to that aforementioned reduction in uncertainty.

With nearly $10 per share in cash and investments, plus its continuing cash-generating ability, I estimate that Bridgepoint has generated nearly $100 million in free cash flow in the past 12 months -- while it was spending to placate WASC -- the stock simply looks too cheap. A return to enrollment growth in 2014, plus realizing even a portion of management's expected $85 million pre-tax cost reductions going forward, suggests fair value of the company lies in the mid-$20s -- substantially above today's share price in the mid-teens.

More stock ideas
We hope you enjoyed our roundtable. If you're itching for more, get a free stock pick from each of our three top-ranked stock-picking services. Just click here


Read/Post Comments (42) | Recommend This Article (120)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On August 02, 2013, at 12:04 PM, sa4rest wrote:

    Controversial is putting it lightly.

    I'm sorry to see Monsanto stock being promoted here. I would never buy it regardless of how well projected earnings might be. This company ruining the crops for the entire world, seed by genetically modified seed.

    I hope to see the stock decline to nothing.

  • Report this Comment On August 02, 2013, at 1:17 PM, Mindspark wrote:

    I agree with the previous post. Monsanto should be boycotted. Wake up people. Health is more important than wealth. Google and YouTube Monsanto; realize and inform others.

  • Report this Comment On August 02, 2013, at 1:19 PM, snapcap wrote:

    sa4rest, on what facts do you base your condemnation of GMO seeds? Is there any medical/scientific evidence supporting your position? I have seen none. Only emotional blathering.

  • Report this Comment On August 02, 2013, at 2:23 PM, ziq wrote:

    Can't get enough controversy, what with fracking and deals with Halliburton, and Citigroup. But I agree that Monsanto is one I wouldn't touch under any circumstances.

  • Report this Comment On August 02, 2013, at 2:33 PM, masterN17 wrote:

    What separates Monsanto from Syngenta, DuPont, Bayer, et al is not the GMO. It is the aggressive legal stance the company takes towards smaller farmers.

    As an example, Monsanto has pushed for adjacent farms to be liable for IP theft if the seeds from Monsanto's own GM crops drift or spread into another farmer's plot, and the farmer harvests and resows the plot. Subsequent lawsuits have supported Monsanto's argument, but an appeals court has had to bind Monsanto not to sue when the redistribution of Monsanto seeds is inadvertent.

    More recently the Farmer's Assurance Provision, spearheaded by Monsanto, allows the growing of GM crops to continue even while legal challenges to its safety are in process. This stands in stark contrast to pharmaceuticals which have to be withdrawn during such challenges.

    Sources:

    http://www.mnn.com/your-home/organic-farming-gardening/stori...

    http://www.huffingtonpost.com/2013/06/10/monsanto-wins-lawsu...

    http://www.monsanto.com/newsviews/Pages/why-does-monsanto-su...

    http://www.pubpat.org/osgatavmonsantocafcdecision.htm

    http://en.wikipedia.org/wiki/Farmer_Assurance_Provision

  • Report this Comment On August 02, 2013, at 2:33 PM, wizmo64 wrote:

    Long term effects from GMO are simply unknown. Educated risk-taking is fine but telling the world not to worry about future unknowns while reaping profits today is why Monsanto is ugly.

  • Report this Comment On August 02, 2013, at 2:44 PM, Crablouse wrote:

    And... Monsanto didn't produce the 7 to 8 billion human mouths to feed either.

  • Report this Comment On August 02, 2013, at 3:54 PM, cellofool100 wrote:

    Monsanto? Really? Do you care about the health of any of us? Your children, your pets, the water you drink? the food you eat? There is a good reason Monsanto has been kicked out of so many countries...Their governments care more about their people's health than profits...Now back to the drawing board and give us truly GREAT August pick.

  • Report this Comment On August 02, 2013, at 5:59 PM, buddyleo wrote:

    I also think Monsanto and Syngenta are the most despicable companies in the States. There are studies to prove some serious health problems. Many nations have banned their GMO products. Please be aware that short term profits do nothing in the long run when biodiversity suffers. Why are Americans so ready to give over their health to Monsanto???

  • Report this Comment On August 02, 2013, at 7:48 PM, spcd7 wrote:

    totally agree with negative sentiment toward monsanto.do some research then decide if they produce what you would eat and feed your children.don't listen to me,do your own unbiased research.

  • Report this Comment On August 02, 2013, at 9:33 PM, fawncee2 wrote:

    the same folks who condemn monsanto will back herbal life because their science background is so weak. If you do not understand scientific method, how can you do any research here?

  • Report this Comment On August 03, 2013, at 12:13 AM, rjherr wrote:

    It has nothing to do with a science background. , fawncee2. Monsanto sucks. I'm disappointed that Motley Fool would even have them listed as a suggestion in the Roundtable. It's like investing in SA before apartheid. It's not ethical. And Roundup has been linked to Parkinson's disease. How smart is that? I wouldn't have anything GMO in my house much less buy the stock. Very disappointing, guys.

  • Report this Comment On August 03, 2013, at 1:04 AM, pkguitarman wrote:

    Maxx should be ashamed for recommending Monsanto. Why invest in an evil company when there are so many other companies?

  • Report this Comment On August 03, 2013, at 12:47 PM, PeterVanKan wrote:

    Okay, also from the Netherlands: how on earth can Monsanto be recommanded here ?

    Those who blabber about schientific evidence etc. have clearly not taken the trouble to get informed. This company is, to put it in one word, evil.

    I need to seriously think about renewing my subscription.

  • Report this Comment On August 03, 2013, at 7:41 PM, allmymarbles wrote:

    I don't care if I could make a million out of Monsanto. I won't touch it. That company is destroying our food supply and making people ill to boot. You should be ashamed to recommend it.

  • Report this Comment On August 03, 2013, at 9:31 PM, hughes57 wrote:

    As soon as I saw Monsanto. I said I would never buy it and I see I am not alone. That company is an evil empire and is the worst of the worst. I am disappointed to see it as a recommendation from Motley Fool.

  • Report this Comment On August 04, 2013, at 12:06 AM, drt2202 wrote:

    Never Ever buying Monsanto. period.

  • Report this Comment On August 04, 2013, at 12:22 AM, sambanova wrote:

    very disappointed to see Monsanto as a Motley Fool pick; can we please do everything possible to make this company and all that it represents go away for good

  • Report this Comment On August 04, 2013, at 9:09 AM, funfundvierzig wrote:

    "Monsanto may receive an unfair amount of criticism for its business (ever hear anyone lament Syngenta, DuPont, or Bayer GMO products?)..."

    Much of DuPont's better, higher tech seeds are mortgaged to Monsanto and embedded with Monsanto's superior GM traits by license. Yet, self-disclosed DuPont AG employees and masked operatives systematically smear and libel Monsanto over the internet in organised fashion! Speaks volumes as to the blatant lack of integrity and innovation in the lagging, number two seed enterprise on the globe. ...funfun..

  • Report this Comment On August 04, 2013, at 10:27 AM, TaichungCanuck wrote:

    I don't doubt for a moment that Monsanto is a horrible company. I for one would certainly not knowingly eat anything GMO, though where I live there is no way of knowing. And I understand the sentiments of many on here about owning the stock (I wouldn't either).

    However, I don't think we should be hard on Motley Fool for recommending it. Their job is not to make our moral decisions for us, but rather to offer investment advice.

    If one objects to investing in any company on moral grounds, then one has the option of not investing in it.

  • Report this Comment On August 05, 2013, at 6:45 AM, JoeBivens wrote:

    Nice strawman, fawncee. No one mentioned Herbal Life but you.

  • Report this Comment On August 05, 2013, at 1:22 PM, techpatriot wrote:

    Forget Monsanto, your best opportunity for a possible double in 12 -18 months is Thompson Creek. I have followed this company for years, and made some money trading around a core position.

    There is more to know about TC than I can write here. Fools, suffice to say it is a grossly undervalued junior mining play getting ready to open one of the most cost effective (lowest cost) open pit copper mines in the free world.

    The company did flirt with financial disaster in transforming itself from a molybdenum only producer to a diversified copper, gold and molybdenum producer over the last 3-4 years, enduring some of the worst market and capex conditions in recent memory. And it is still priced accordingly with that risk in mind.

    The mine is now 97% complete and will be producing copper and gold next quarter. Unfortunately, due to the fact far too many investors that have not done any due diligence here, they will dismiss TC as just another junior gold miner caught up in the gold price bloodbath. When the reality is Mt Milligan will transform TC (primarily) into a low cost cost, diversified industrial metal producer.

    Despite the macro economic climate, the China slowdown, and all the rest of the bad news over the last year or two, even at today's low prices their new greenfield property should generate "well over" $1 of free cash flow, not too bad for a $3 stock. Even in the extremely unlikely event all metals prices were to tank 50% from where they are now, TC would still be okay, and be able to survive until they turned around.

    As mentioned, the recent financial disaster scenarios are now off the table, even if that fact is not yet reflected in the stock price,

    As the company uses this cash flow to effect debt deleveraging over the next year or two the stock should end up trading somewhere between 6 and 10 times earnings, on a conservative basis.

    And if molybdenum or copper prices recover meaningfully at anytime in the next 3-6 years it will provide quite a kicker for the stock price. So holding this in a foolish manner for an extended time frame could yield a possible 5 or 6 bagger as world markets recover, assuming TC does not get bought out first. The extent of this "foolish time frame" is dependent on macro environments which none of us can control.

    The catalyst news may start with the conference call next week, or it may start with the next conference call, but it will come. And waiting until it does come before staking your positions could be a costly move.

  • Report this Comment On August 05, 2013, at 6:39 PM, ghstflame wrote:

    RAD and ALU are the picks of the year, perhaps decade.

  • Report this Comment On August 05, 2013, at 6:55 PM, lowmaple wrote:

    Yes Monsanto is a despicable company. But their politcal hold is one reason they will be a good investment. However as other's have said I cannot feel comforatable buying it. So someone else will make even more money.

  • Report this Comment On August 05, 2013, at 8:17 PM, tombland wrote:

    I'm also really disappointed to see Monsanto given the time of day here, although yes we can of course choose to disregard the recommendation.

    Monsanto's products are heavily implicated in the ongoing devastation to the bee population – a major crisis on many levels. Monsanto claim there is no supporting evidence of course, despite there being plenty. I'd like to take this opportunity to ask that anyone interested sign this petition asking congress to ban the pesticide that is killing bees: http://org.credoaction.com/petitions/tell-congress-stop-the-...

    Thanks...

  • Report this Comment On August 05, 2013, at 9:46 PM, antipolis wrote:

    Add my name to those who would never buy a GMO product, ever. To buy Monsanto would be the same as looking the other way as Jews were being herded into the ovens. Monsanto is morally wrong. Why on earth would anyone support such a company? For Motley Fool to recommend such a stock makes me think that profit is more important than integrity.

  • Report this Comment On August 05, 2013, at 10:18 PM, ershler wrote:

    Maxx,

    I agree with you; I recently took a large pay cut to leave Halliburton and return to Monsanto after a two hiatus.

  • Report this Comment On August 06, 2013, at 12:31 AM, sux4972 wrote:

    As the son of a farmer, a brother to three other farmers, and as a veterinarian I see companies such as Monsanto, which I have owned for three years, as being an important tool for the world's farmers to produce food not just for us, but also for export to feed the starving in third world countries. GMO seeds allow us to do just that. These Round-up tolerant seeds produce much higher yields with less herbacide per acre.

    Thus they are safer environmentally and able to feed greater populations. Man has modified grain and meat production through selective breeding of plants and animals since we first started raising grains & livestock for food. Monsanto and the others have just found a way to speed up the process and make it safer for all of us. The herbicides and insecticides are and will be used, so why not use a GMO seed and use less of them, and thus minimize the environmental impact? As for me I am long Monsanto. only fools boycott, REAL FOOLS

    INVEST!

  • Report this Comment On August 06, 2013, at 12:48 AM, TMFJoeInvestor wrote:

    Not to speak for Maxx, but the purpose of this roundtable is to present (free) investing ideas for you to choose from. It's up to you to filter them based upon your own values, needs, and risk tolerance.

  • Report this Comment On August 06, 2013, at 2:44 AM, rocker101 wrote:

    Monsanto is despicable and I don't want anything to do with their stock under any circumstances.

  • Report this Comment On August 06, 2013, at 5:48 AM, mrplow2000 wrote:

    Hilarious that many of the posts condemning Monsanto are from first time Motley Fool users, no doubt there is a group somewhere who target any forums or web articles which discuss Monsanto and their products/ business.

    Personally I am really tempted to invest. The fundamentals look good:

    http://simplistickr.com/MON

    AND there is one thing you can be certain on.. the world is only going to need more food.

  • Report this Comment On August 07, 2013, at 11:03 AM, techpatriot wrote:

    Ok - as I am trying not to get caught up in this crazy Monsanto Sharknado that is going on here, I've put some additional information on about TC on the Motley Fool TC board.

    So if you want a little more info on Thompson Creek to see if it might be a fit your portfolio, take a look at TMF TC board.

    I have posted some information of interest on TC there that Fools should find quite interesting.

    GLTA!

    (Whew, who knew Monsanto was such an emotional topic?)

  • Report this Comment On August 07, 2013, at 1:28 PM, AMDG4 wrote:

    I would love to buy Monsanto. It is a pipe dream of mine to have all concerned citizens buy enough shares to get a majority vote to put them out of business.

    But, I wouldn't touch the stock as part of my portfolio, even if it was the, bar none, cream of the investment crop. I am just not interested in being part of something so downright evil.

  • Report this Comment On August 07, 2013, at 11:54 PM, 123spot wrote:

    Good heavens, has no one here taken a basic science class? Spot

  • Report this Comment On August 09, 2013, at 1:27 PM, NCMichael wrote:

    I concur with TaichungCanuck. The purpose of this article was to make stock recommendations, not save the world from evil corporate giants. It's up to you to decide which stocks are appropriate for you.

  • Report this Comment On August 11, 2013, at 7:31 PM, decebalvs wrote:

    Reccomending stocks of companies that do so much damage, is like reccomending investing in a burgler, based on the fact that they seem to do well so far.

    Sooner or later they end up in jail, where they belong.

  • Report this Comment On August 13, 2013, at 10:45 AM, Hoarder wrote:

    I acted on the advice regarding TC and am so far happy to have done so.

    This bit of light reading may be of interest to others:

    http://seekingalpha.com/article/1628232-a-perfect-trifecta-f...

  • Report this Comment On August 18, 2013, at 11:43 AM, TurboJohn wrote:

    Attorneys are running Monsanto. They have convinced the operatives (CEOs and EVPs) that protection of their GMO seeds should be conducted at all costs. Their blackballing of farms that refuse to use Monsanto's seeds smack of Rockefeller's trust building through intimidation 100 yr ago. Read the history books. And the attorneys are the real winners, claiming a growing portion of corporate profits to litigate with small farmers. Heard that story before.

    China's demand for copper has abated and will not return to high levels. Plenty of stories about see-through apt and commercial buildings (read empty of tenants) that consumed high quantities of copper during the boom-level of construction that came to a screeching halt in 2012 or earlier. I follow copper prices in my business. $4.00 per lb copper during 2012 got its last boost at the tail of boom-buying from inflation by the US Govn "monetary easing" actions, continuing to 2013. If it weren't for those inflationary effects, currebt $3.30 copper would be below $3.00 per lb. Thompson Creek's mine needs to be profitable with $3.00 copper.

    Were mining stocks overheated? $1800 gold retreated to $1200 but has come back to mid $1300s where it will probably stay, more or less, for the next few years, until all the speculators complete their dumping of their holdings, then who knows were it will go. Gold continues as the oxidation preventer of choice (as a coating) for pin connections on all types of electronic devices that work on low voltage, less than 10 volts. So future demand for gold is related to the future of physical electronic devices.

    Molybdenum as an alloying element in the 0.5 to 8.0 percent level allows steel to withstand temperatures in excess of 750 degrees F (399C). Plenty will be used in Sasol's 2014 petrochemical project in southwest Louisiana, but more than one such large-scale high temperature processing facility is needed to suggest demand will increase above current levels. Otherwise, Thompson Creek's project is limited to replacing old mines that are playing out. Nothing wrong with that, but is different than implementing early in a multi-year era where demand growth can be expected.

    I have enthusiasm for any mine project in North America, as these mines will be friendlier to our fragile planet than those in some countries. This one is in British Columbia. But some hard unit production values are needed to convince me of $1 per share of free cash flow. Worth looking into.

  • Report this Comment On August 19, 2013, at 8:59 AM, explorer4711 wrote:

    Dear fools,

    can you please give me your assessment on

    o´Reilly Automotive .

    Best Regards,

    Axel B.

  • Report this Comment On August 19, 2013, at 4:01 PM, whyaduck1128 wrote:

    I'm as uncomfortable with Monsanto as anyone. BUT since this is an investment forum and not a "social responsibility" weepy-whiny site for people to moan and carp about just about everything, I suggest that we stick to Monsanto as an investment and leave the "good vs. evil" stuff aside.

    Personally, I won't invest in it, just as I won't buy the big banks (such as the loathsome C and JPM) and major media companies, but that's just me. I'm here for investment advice; I can do the social/political/ethical/legal/philosophical math on my own.

  • Report this Comment On August 20, 2013, at 12:41 PM, miket3512 wrote:

    Glad to see the anti-monsanto sentiment. Not pleased to see the stock recommended, as well as "sux4972" ignorant comments. Anyone who thinks it's ok to ingest something that's both doused in and immune to Roundup is idiotic. Enjoy your cancer.

  • Report this Comment On September 21, 2013, at 2:01 PM, jaybird43 wrote:

    Really? Everyone is dumping on Monsanto but everyone is ok with Citi, the home of the reverse split. Sandy Weill must still be running this dog!

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2576333, ~/Articles/ArticleHandler.aspx, 9/17/2014 1:34:05 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement